Rocket Lab (NASDAQ: RKLB) plans $75M Mynaric acquisition plus earnout

Rhea-AI Filing Summary

Rocket Lab Corporation is entering the optical communications market more deeply by agreeing to acquire all outstanding shares of German company Mynaric AG. Under the Stock Purchase Agreement, Rocket Lab’s subsidiary will purchase Mynaric for aggregate consideration of $75 million, payable in cash or Rocket Lab common stock at the company’s discretion, subject to closing adjustments. The deal also includes up to an additional $75 million in potential post-closing earnout payments in cash or stock, tied to Mynaric’s revenue performance for 2025, 2026 and 2027.

Any Rocket Lab stock issued in the transaction or as earnout will be valued using the 20-day volume-weighted average price before closing or the earnout payment date. These shares will be issued in a private offering relying on exemptions from SEC registration, and Rocket Lab has committed to file a resale registration statement for such shares within 30 days after closing. Completion of the acquisition is still subject to regulatory approval from the German Ministry of Foreign Affairs.

Insights

M&A and Capital Markets Analyst

Rocket Lab agrees to buy Mynaric for $75M plus earnout, with flexible cash/stock structure.

Rocket Lab is using its wholly owned subsidiary to acquire all shares of Mynaric AG for aggregate consideration of $75 million, payable in cash or Rocket Lab common stock at its discretion, subject to closing adjustments. The agreement also includes up to an additional $75 million in potential earnout payments based on revenue targets for 2025, 2026 and 2027, allowing part of the price to depend on Mynaric’s future performance.

Any Rocket Lab shares issued for the upfront consideration or earnouts will be valued using the 20-day volume-weighted average trading price before the relevant date, which ties stock consideration to an average market price rather than a single day. The equity will be issued in a private, unregistered transaction under Section 4(a)(2) and/or Regulation D, and Rocket Lab has agreed to file a resale registration statement for these shares within 30 days after the closing date. Closing remains contingent on regulatory approval by the German Ministry of Foreign Affairs, so timing and final structure depend on that approval and subsequent post-closing performance against the specified revenue targets.

8-K Event Classification

2 items: 3.02, 8.01

2 items

Item 3.02 Unregistered Sales of Equity Securities Securities

The company sold equity securities in a private placement or other unregistered transaction.

Item 8.01 Other Events Other

Voluntary disclosure of events the company deems important to shareholders but not covered by other items.

Understanding 8-K Material Events →

FALSE000181999400018199942025-09-252025-09-25

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): September 25, 2025

ROCKET LAB CORPORATION

(Exact name of Registrant as Specified in Its Charter)

Delaware			001-39560			39-2182599
(State or Other Jurisdiction of Incorporation)			(Commission File Number)			(IRS Employer Identification No.)
3881 McGowen Street
Long Beach, California						90808
(Address of Principal Executive Offices)						(Zip Code)

Registrant’s Telephone Number, Including Area Code: 714 465-5737

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, par value $0.0001 per share

RKLB

The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 3.02 Unregistered Sales of Equity Securities.

The information set forth in Item 8.01 of this Current Report on Form 8-K is incorporated by reference into this Item 3.02. The Company Common Stock consideration to be issued, if any, in connection with the Transaction will be issued in reliance upon an exemption from the registration requirements of the Securities Act of 1933, as amended, pursuant to Section 4(a)(2) thereof and/or Regulation D thereunder, as a transaction by an issuer not involving a public offering.

Item 8.01 Other Items.

On September 25, 2025, Rocket Lab Corporation, a Delaware corporation (the “Company”), entered into a Stock Purchase Agreement (together with the ancillary documents thereto, the “Purchase Agreement”), by and among the Company, Rocket Lab USA, Inc., a Delaware corporation and wholly-owned subsidiary of the Company (“Buyer”), OC III LVS LIII LP, a Delaware limited partnership (“OC III”) and CO Finance II LVS I LLC, a Delaware limited liability company (“COF II” and together with OC III, the “Sellers”), which provides for, among other things, Buyer’s purchase and acquisition of all of the issued and outstanding ordinary shares of Mynaric AG, a stock corporation (Aktiengesellschaft) incorporated under the laws of the Federal Republic of Germany (“Mynaric”).

Pursuant to the terms of the Purchase Agreement, all of the issued and outstanding ordinary shares of Mynaric will be purchased in exchange for aggregate consideration of $75 million, consisting in cash or shares of the Company’s common stock, $0.0001 par value (“Company Common Stock”), at the Company’s discretion, subject to adjustments at closing (the “Transaction”). Additionally, the Purchase Agreement provides for up to $75 million in potential additional post-closing earnout payments to Sellers in cash or shares of Company Common Stock based on revenue targets of the Mynaric business for 2025, 2026 and 2027. The Company Common Stock issuable as stock consideration in the Transaction will be valued based on the volume weighted average price for the twenty (20) consecutive trading days ending on (and including) the trading day that is immediately preceding the day prior to the Closing Date (as defined in the Purchase Agreement) or the earnout payment date, as applicable.

The Purchase Agreement contains representations, warranties, covenants and closing conditions from and for the benefit of each of the Company and Sellers that are customary for transactions of this kind. The Company has also agreed to file a resale registration statement with respect to the Company Common Stock issued in the Transaction within 30 days after the Closing Date, subject to certain customary exceptions and requirements as well as customary selling securityholder indemnities with respect to such registration rights. The Transaction is subject to regulatory approval by the German Ministry of Foreign Affairs.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

									ROCKET LAB CORPORATION
Date:			September 25, 2025			By:			/s/ Adam Spice
									Adam Spice Chief Financial Officer

FAQ

What transaction did Rocket Lab (RKLB) announce involving Mynaric AG?

Rocket Lab Corporation agreed to a Stock Purchase Agreement under which its subsidiary will acquire all issued and outstanding ordinary shares of Mynaric AG, a German stock corporation, from existing sellers.

How much is Rocket Lab (RKLB) paying to acquire Mynaric AG?

Rocket Lab will pay aggregate consideration of $75 million for all outstanding Mynaric shares, in cash or Rocket Lab common stock at the companys discretion, subject to closing adjustments.

Is there an earnout component in Rocket Labs purchase of Mynaric?

Yes. The Purchase Agreement provides for up to an additional $75 million in potential post-closing earnout payments to the sellers in cash or Rocket Lab common stock, based on revenue targets of the Mynaric business for 2025, 2026 and 2027.

How will the Rocket Lab (RKLB) stock issued in the Mynaric deal be valued?

Any Rocket Lab common stock issued as consideration or earnout will be valued using the volume weighted average price for the 20 consecutive trading days ending on the trading day immediately preceding the day prior to the closing date or the earnout payment date, as applicable.

Will Rocket Lab register the shares issued in the Mynaric acquisition?

Rocket Lab expects to issue any stock consideration in a private transaction relying on exemptions from SEC registration, and has agreed to file a resale registration statement for the Rocket Lab common stock issued in the transaction within 30 days after the closing date, subject to customary exceptions and requirements.

What regulatory approvals are required for Rocket Lab to complete the Mynaric acquisition?

Completion of the transaction is subject to regulatory approval by the German Ministry of Foreign Affairs, as specified in the Purchase Agreement.